Share
Market Research Report

DEMENTIA DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Drug ClassMAO Inhibitors · Cholinesterase Inhibitors · Glutamate Inhibitor · and Others
  • By IndicationAlzheimer’s Disease Dementia · Lewy Body Dementia · Parkinson Disease Dementia · and Others
  • By Route of AdministrationOral · Intravenous · and Others
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By GeographyNorth America · Latin America · Asia Pacific · Europe · Middle East · and Africa
  • Published In01 Apr 2026
  • Report CodeCMI1664
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Dementia Drugs Market, By Drug Class
      • Dementia Drugs Market, By Indication
      • Dementia Drugs Market, By Route of Administration
      • Dementia Drugs Market, By Distribution Channel
      • Dementia Drugs Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Epidemiology
    • Pipeline Analysis
  4. Dementia Drugs Market, By Drug Class, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • MAO Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Cholinesterase Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Glutamate Inhibitor
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Dementia Drugs Market, By Indication, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Alzheimer’s Disease Dementia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Lewy Body Dementia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Parkinson Disease Dementia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Dementia Drugs Market, By Route of Administration, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Intravenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Dementia Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Dementia Drugs Market, By Region, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, (USD Bn)
      • Regional Trends
    • North America

      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America

      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe

      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific

      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East

      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa

      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape

    • Biogen
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eisai Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Cipla
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Lundbeck A/S
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Otsuka Pharmaceutical Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sun Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Viatris Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Mapi-Pharma Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • DAIICHI SANKYO COMPANY, LIMITED.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • F.Hoffmann-La Roche Ltd
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  10. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 34 market data tables and 30 figures on 'Dementia Drugs Market' - Global forecast to 2033